Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices

Short summary

An autonomous AI system achieved 87.2% sensitivity and 90.7% specificity in detecting more than mild diabetic retinopathy (mtmDR) in a pivotal trial, leading to its FDA authorization as the first autonomous AI diagnostic system in medicine.

AI-generated from the title and abstract; the full text is not read.